Electromed has delivered strong revenue growth and margin improvement but faces a highly competitive, fragmented market for its SmartVest product. ELMD lacks a durable moat, with rivals like Tactile ...

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six ...

Electromed Inc. (ELMD) reported strong financial results for the second quarter of fiscal year 2026, surpassing earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.32, ...

Net revenues increased 16.3% to a record $18.9 million in Q2 FY 2026, from $16.3 million in the second quarter of the prior fiscal year, led by an 18.4% increase in the core homecare market. Operating ...

Electromed develops and markets medical devices in the respiratory care field. Its main product is the SmartVest System, which delivers High Frequency Chest Wall Oscillation (HFCWO) therapy to help ...

Electromed, Inc. (NYSE:ELMD) is one of the 11 Best Long Term Low Risk Stocks to Invest in. Analysts maintain a Buy rating stock amid strong Q3 earnings and the company’s inclusion in the Russell 2000 ...

Fintel reports that on July 22, 2025, Roth Capital initiated coverage of Electromed (NYSEAM:ELMD) with a Buy recommendation. Analyst Price Forecast Suggests 86.77% Upside As of July 17, 2025, the ...

The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to ...

Imagine this: you’re in the middle of an important project, juggling deadlines, and collaborating with a team scattered across time zones. Suddenly, your computer crashes, and hours of work vanish in ...